tirzepatide 3ml Flex-Dose 3 mL Injectable 10 mg/mL Tirzepatide 30mg | Proven GLP-1

Consider a common scenario

In the SURPASS-2 trial published in the New England Journal of Medicine, tirzepatide at 15 mg produced an average weight loss of 11.2 kg compared to 5.7 kg with semaglutide 1 mg over 40 weeks

Tirzepatide can cause gastrointestinal issues like diarrhea, vomiting, constipation, and stomach pain

Here are some adverse effects of this GLP-1 agonist: Common side effects Nausea is one of the most common side effects of Semaglutide, and it can be very common when you first begin taking the medication or when your dose is increased

A direct-to-consumer platform (TrumpRx), launched in January 2026, offers GLP-1s at roughly $350/month ( [23] )

Every bite needs to count nutritionally since total food intake decreases substantially